Quarterly report pursuant to Section 13 or 15(d)

Restructuring (Tables)

v3.23.1
Restructuring (Tables)
 3 Months Ended
Mar. 31, 2023
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring and Related Costs
Future Estimated Restructuring Expense by Segment (in millions)
Medical Industrial Corporate Total
$ 0.6  $ 0.4  $ 0.1  $ 1.1 
The following table summarizes restructuring expenses for each reportable segment (in millions):
Three Months Ended
March 31,
2023 2022
Restructuring expenses:
Medical $ 0.3  $ 1.5 
Industrial 0.1  — 
Corporate and other 1.0  0.5 
Total $ 1.4  $ 2.0 
The following table summarizes the changes in the Company’s accrued restructuring balance, which are included in Accrued expenses and other current liabilities in the accompanying Condensed Consolidated Balance Sheets (in millions).
Balance at December 31, 2022 $ 1.5 
Restructuring charges 1.4 
Payments (0.6)
Adjustments — 
Balance at March 31, 2023 $ 2.3 
Schedule of Restructuring Reserve by Type of Cost
The Company’s restructuring expenses are comprised of the following (in millions):
Three Months Ended March 31, 2023
Cost of revenue Selling, general
 and administrative		 Total
Severance and employee costs $ —  $ 1.2  $ 1.2 
Other(1)
—  0.2  0.2 
Total $ —  $ 1.4  $ 1.4 
Three Months Ended March 31, 2022
Cost of revenue Selling, general
 and administrative		 Total
Severance and employee costs $ 0.1  $ 0.9  $ 1.0 
Other(1)
—  1.0  1.0 
Total $ 0.1  $ 1.9  $ 2.0 
(1) Includes facilities, inventory write-downs, outside services, legal matters, and IT costs.